These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Potential role of temocillin in the treatment of biliary sepsis. Uwaydah M; Vartivarian S; Harakeh H; Awdeh A; Najjar F Drugs; 1985; 29 Suppl 5():186-90. PubMed ID: 4029024 [TBL] [Abstract][Full Text] [Related]
34. Comparison between the pharmacokinetic properties of mezlocillin when given intravenously as a bolus injection or as an infusion. Ohlsson H; Bergan T Arzneimittelforschung; 1979; 29(12a):1958-9. PubMed ID: 543900 [TBL] [Abstract][Full Text] [Related]
35. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin. Bergan T; Thorsteinsson SB; Steingrimsson O Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of azlocillin after discontinuous intravenous administration of high dose. Naber KG; Adam D J Antimicrob Chemother; 1983 May; 11 Suppl B():115-20. PubMed ID: 6619021 [TBL] [Abstract][Full Text] [Related]
37. Temocillin elimination in patients with varying degrees of renal failure. Wright N; Wise R; Price JD J Antimicrob Chemother; 1983 May; 11(5):481-4. PubMed ID: 6874633 [TBL] [Abstract][Full Text] [Related]
38. Thrice-weekly temocillin administered after each dialysis session is appropriate for the treatment of serious Gram-negative infections in haemodialysis patients. Vandecasteele SJ; Miranda Bastos AC; Capron A; Spinewine A; Tulkens PM; Van Bambeke F Int J Antimicrob Agents; 2015 Dec; 46(6):660-5. PubMed ID: 26603304 [TBL] [Abstract][Full Text] [Related]
39. Human pharmacokinetics and antimicrobial activities of the temocillin epimers. Guest EA; Horton R; Mellows G; Slocombe B; Swaisland AJ; Tasker TC; White AR Drugs; 1985; 29 Suppl 5():154-61. PubMed ID: 4029021 [TBL] [Abstract][Full Text] [Related]